Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mitochondrial autophagy-related gene signatures associated with myasthenia gravis diagnosis and immunity

12 Feb 2025

Abstract excerpt

Myasthenia gravis (MG) is a common autoimmune disorder that causes skeletal muscle weakness. Most patients presented with skeletal muscle weakness and endurance decline. Mitophagy refers to removing and interpreting aging or damaged mitochondria in cells. This plays a vital role in maintaining cell homeostasis and normal function. This study explores the role of mitophagy-related genes (GM) in MG. Specifically,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Myasthenia Gravis and Thymoma
Share to Parkinson's Disease and Spinal Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39937929
DOI: 10.1080/08916934.2025.2465410

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mitochondrial autophagy-related gene signatures associated with myasthenia gravis diagnosis and immunityPMID 39937929Read ↗

Mitochondrial dysfunction in myasthenia gravis: Exploring directions for future immunotherapy? A reviewSemantic proximity Read ↗

Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravisSemantic proximity Read ↗

Autophagy-related genes are potential diagnostic biomarkers for dermatomyositisSemantic proximity Read ↗

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravisSemantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patientsSemantic proximity Read ↗

Identification of key regulatory factors for m6A in myasthenia gravis and characteristics of the immune characteristicsSemantic proximity Read ↗

Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravisSemantic proximity Read ↗

Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis.Semantic proximity Read ↗

Defective autophagy and autophagy activators in myasthenia gravis: a rare entity and unusual scenarioSemantic proximity Read ↗

Identification of mitophagy-related biomarkers in human rheumatoid arthritis using machine learning modelsSemantic proximity Read ↗

CFD+CD14+ monocytes: potential pathogenic subset in myasthenia gravis uncovered by multi-omics integration and machine learning analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.